Global Human Micobiome Market Size, Status and Forecast 2020-2026
The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
The research usually can last 8-10 years, so scale production will occur in 2018. Before then, the Human Micobiome companies have to continue deficit.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Human Micobiome market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Human Micobiome industry.
Based on our recent survey, we have several different scenarios about the Human Micobiome YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 256.2 million in 2019. The market size of Human Micobiome will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Micobiome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Micobiome market in terms of revenue.
Players, stakeholders, and other participants in the global Human Micobiome market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Human Micobiome market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Human Micobiome market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Micobiome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Micobiome market.
The following players are covered in this report:
These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
The research usually can last 8-10 years, so scale production will occur in 2018. Before then, the Human Micobiome companies have to continue deficit.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Human Micobiome market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Human Micobiome industry.
Based on our recent survey, we have several different scenarios about the Human Micobiome YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 256.2 million in 2019. The market size of Human Micobiome will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Micobiome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Micobiome market in terms of revenue.
Players, stakeholders, and other participants in the global Human Micobiome market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Human Micobiome market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Human Micobiome market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Micobiome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Micobiome market.
The following players are covered in this report:
- Vedanta
- Seres Therapeutics
- Second Genome
- Rebiotix
- ActoGeniX
- Enterome BioScience
- AvidBiotics
- 4D Pharma Research Ltd
- Enterologics
- Metabogen
- Metabiomics
- Ritter Pharmaceuticals
- Osel
- Symberix
- Miomics
- Symbiotix Biotherapies
- MicroBiome Therapeutics LLC
- Gastrointestinal Tract Human Micobiome
- Urogenital Tract Human Micobiome
- Other
- Treatment
- Diagnosis
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Human Micobiome Revenue
1.4 Market Analysis by Type
1.4.1 Global Human Micobiome Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Gastrointestinal Tract Human Micobiome
1.4.3 Urogenital Tract Human Micobiome
1.4.4 Other
1.5 Market by Application
1.5.1 Global Human Micobiome Market Share by Application: 2020 VS 2026
1.5.2 Treatment
1.5.3 Diagnosis
1.6 Coronavirus Disease 2019 (Covid-19): Human Micobiome Industry Impact
1.6.1 How the Covid-19 is Affecting the Human Micobiome Industry
1.6.1.1 Human Micobiome Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Human Micobiome Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Human Micobiome Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Human Micobiome Market Perspective (2015-2026)
2.2 Human Micobiome Growth Trends by Regions
2.2.1 Human Micobiome Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Human Micobiome Historic Market Share by Regions (2015-2020)
2.2.3 Human Micobiome Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Human Micobiome Market Growth Strategy
2.3.6 Primary Interviews with Key Human Micobiome Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Human Micobiome Players by Market Size
3.1.1 Global Top Human Micobiome Players by Revenue (2015-2020)
3.1.2 Global Human Micobiome Revenue Market Share by Players (2015-2020)
3.1.3 Global Human Micobiome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Human Micobiome Market Concentration Ratio
3.2.1 Global Human Micobiome Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Human Micobiome Revenue in 2019
3.3 Human Micobiome Key Players Head office and Area Served
3.4 Key Players Human Micobiome Product Solution and Service
3.5 Date of Enter into Human Micobiome Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Human Micobiome Historic Market Size by Type (2015-2020)
4.2 Global Human Micobiome Forecasted Market Size by Type (2021-2026)
5 HUMAN MICOBIOME BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Human Micobiome Market Size by Application (2015-2020)
5.2 Global Human Micobiome Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Human Micobiome Market Size (2015-2020)
6.2 Human Micobiome Key Players in North America (2019-2020)
6.3 North America Human Micobiome Market Size by Type (2015-2020)
6.4 North America Human Micobiome Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Human Micobiome Market Size (2015-2020)
7.2 Human Micobiome Key Players in Europe (2019-2020)
7.3 Europe Human Micobiome Market Size by Type (2015-2020)
7.4 Europe Human Micobiome Market Size by Application (2015-2020)
8 CHINA
8.1 China Human Micobiome Market Size (2015-2020)
8.2 Human Micobiome Key Players in China (2019-2020)
8.3 China Human Micobiome Market Size by Type (2015-2020)
8.4 China Human Micobiome Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Human Micobiome Market Size (2015-2020)
9.2 Human Micobiome Key Players in Japan (2019-2020)
9.3 Japan Human Micobiome Market Size by Type (2015-2020)
9.4 Japan Human Micobiome Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Human Micobiome Market Size (2015-2020)
10.2 Human Micobiome Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Human Micobiome Market Size by Type (2015-2020)
10.4 Southeast Asia Human Micobiome Market Size by Application (2015-2020)
11 INDIA
11.1 India Human Micobiome Market Size (2015-2020)
11.2 Human Micobiome Key Players in India (2019-2020)
11.3 India Human Micobiome Market Size by Type (2015-2020)
11.4 India Human Micobiome Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Human Micobiome Market Size (2015-2020)
12.2 Human Micobiome Key Players in Central & South America (2019-2020)
12.3 Central & South America Human Micobiome Market Size by Type (2015-2020)
12.4 Central & South America Human Micobiome Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Vedanta
13.1.1 Vedanta Company Details
13.1.2 Vedanta Business Overview and Its Total Revenue
13.1.3 Vedanta Human Micobiome Introduction
13.1.4 Vedanta Revenue in Human Micobiome Business (2015-2020))
13.1.5 Vedanta Recent Development
13.2 Seres Therapeutics
13.2.1 Seres Therapeutics Company Details
13.2.2 Seres Therapeutics Business Overview and Its Total Revenue
13.2.3 Seres Therapeutics Human Micobiome Introduction
13.2.4 Seres Therapeutics Revenue in Human Micobiome Business (2015-2020)
13.2.5 Seres Therapeutics Recent Development
13.3 Second Genome
13.3.1 Second Genome Company Details
13.3.2 Second Genome Business Overview and Its Total Revenue
13.3.3 Second Genome Human Micobiome Introduction
13.3.4 Second Genome Revenue in Human Micobiome Business (2015-2020)
13.3.5 Second Genome Recent Development
13.4 Rebiotix
13.4.1 Rebiotix Company Details
13.4.2 Rebiotix Business Overview and Its Total Revenue
13.4.3 Rebiotix Human Micobiome Introduction
13.4.4 Rebiotix Revenue in Human Micobiome Business (2015-2020)
13.4.5 Rebiotix Recent Development
13.5 ActoGeniX
13.5.1 ActoGeniX Company Details
13.5.2 ActoGeniX Business Overview and Its Total Revenue
13.5.3 ActoGeniX Human Micobiome Introduction
13.5.4 ActoGeniX Revenue in Human Micobiome Business (2015-2020)
13.5.5 ActoGeniX Recent Development
13.6 Enterome BioScience
13.6.1 Enterome BioScience Company Details
13.6.2 Enterome BioScience Business Overview and Its Total Revenue
13.6.3 Enterome BioScience Human Micobiome Introduction
13.6.4 Enterome BioScience Revenue in Human Micobiome Business (2015-2020)
13.6.5 Enterome BioScience Recent Development
13.7 AvidBiotics
13.7.1 AvidBiotics Company Details
13.7.2 AvidBiotics Business Overview and Its Total Revenue
13.7.3 AvidBiotics Human Micobiome Introduction
13.7.4 AvidBiotics Revenue in Human Micobiome Business (2015-2020)
13.7.5 AvidBiotics Recent Development
13.8 4D Pharma Research Ltd
13.8.1 4D Pharma Research Ltd Company Details
13.8.2 4D Pharma Research Ltd Business Overview and Its Total Revenue
13.8.3 4D Pharma Research Ltd Human Micobiome Introduction
13.8.4 4D Pharma Research Ltd Revenue in Human Micobiome Business (2015-2020)
13.8.5 4D Pharma Research Ltd Recent Development
13.9 Enterologics
13.9.1 Enterologics Company Details
13.9.2 Enterologics Business Overview and Its Total Revenue
13.9.3 Enterologics Human Micobiome Introduction
13.9.4 Enterologics Revenue in Human Micobiome Business (2015-2020)
13.9.5 Enterologics Recent Development
13.10 Metabogen
13.10.1 Metabogen Company Details
13.10.2 Metabogen Business Overview and Its Total Revenue
13.10.3 Metabogen Human Micobiome Introduction
13.10.4 Metabogen Revenue in Human Micobiome Business (2015-2020)
13.10.5 Metabogen Recent Development
13.11 Metabiomics
10.11.1 Metabiomics Company Details
10.11.2 Metabiomics Business Overview and Its Total Revenue
10.11.3 Metabiomics Human Micobiome Introduction
10.11.4 Metabiomics Revenue in Human Micobiome Business (2015-2020)
10.11.5 Metabiomics Recent Development
13.12 Ritter Pharmaceuticals
10.12.1 Ritter Pharmaceuticals Company Details
10.12.2 Ritter Pharmaceuticals Business Overview and Its Total Revenue
10.12.3 Ritter Pharmaceuticals Human Micobiome Introduction
10.12.4 Ritter Pharmaceuticals Revenue in Human Micobiome Business (2015-2020)
10.12.5 Ritter Pharmaceuticals Recent Development
13.13 Osel
10.13.1 Osel Company Details
10.13.2 Osel Business Overview and Its Total Revenue
10.13.3 Osel Human Micobiome Introduction
10.13.4 Osel Revenue in Human Micobiome Business (2015-2020)
10.13.5 Osel Recent Development
13.14 Symberix
10.14.1 Symberix Company Details
10.14.2 Symberix Business Overview and Its Total Revenue
10.14.3 Symberix Human Micobiome Introduction
10.14.4 Symberix Revenue in Human Micobiome Business (2015-2020)
10.14.5 Symberix Recent Development
13.15 Miomics
10.15.1 Miomics Company Details
10.15.2 Miomics Business Overview and Its Total Revenue
10.15.3 Miomics Human Micobiome Introduction
10.15.4 Miomics Revenue in Human Micobiome Business (2015-2020)
10.15.5 Miomics Recent Development
13.16 Symbiotix Biotherapies
10.16.1 Symbiotix Biotherapies Company Details
10.16.2 Symbiotix Biotherapies Business Overview and Its Total Revenue
10.16.3 Symbiotix Biotherapies Human Micobiome Introduction
10.16.4 Symbiotix Biotherapies Revenue in Human Micobiome Business (2015-2020)
10.16.5 Symbiotix Biotherapies Recent Development
13.17 MicroBiome Therapeutics LLC
10.17.1 MicroBiome Therapeutics LLC Company Details
10.17.2 MicroBiome Therapeutics LLC Business Overview and Its Total Revenue
10.17.3 MicroBiome Therapeutics LLC Human Micobiome Introduction
10.17.4 MicroBiome Therapeutics LLC Revenue in Human Micobiome Business (2015-2020)
10.17.5 MicroBiome Therapeutics LLC Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Human Micobiome Revenue
1.4 Market Analysis by Type
1.4.1 Global Human Micobiome Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Gastrointestinal Tract Human Micobiome
1.4.3 Urogenital Tract Human Micobiome
1.4.4 Other
1.5 Market by Application
1.5.1 Global Human Micobiome Market Share by Application: 2020 VS 2026
1.5.2 Treatment
1.5.3 Diagnosis
1.6 Coronavirus Disease 2019 (Covid-19): Human Micobiome Industry Impact
1.6.1 How the Covid-19 is Affecting the Human Micobiome Industry
1.6.1.1 Human Micobiome Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Human Micobiome Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Human Micobiome Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Human Micobiome Market Perspective (2015-2026)
2.2 Human Micobiome Growth Trends by Regions
2.2.1 Human Micobiome Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Human Micobiome Historic Market Share by Regions (2015-2020)
2.2.3 Human Micobiome Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Human Micobiome Market Growth Strategy
2.3.6 Primary Interviews with Key Human Micobiome Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Human Micobiome Players by Market Size
3.1.1 Global Top Human Micobiome Players by Revenue (2015-2020)
3.1.2 Global Human Micobiome Revenue Market Share by Players (2015-2020)
3.1.3 Global Human Micobiome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Human Micobiome Market Concentration Ratio
3.2.1 Global Human Micobiome Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Human Micobiome Revenue in 2019
3.3 Human Micobiome Key Players Head office and Area Served
3.4 Key Players Human Micobiome Product Solution and Service
3.5 Date of Enter into Human Micobiome Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Human Micobiome Historic Market Size by Type (2015-2020)
4.2 Global Human Micobiome Forecasted Market Size by Type (2021-2026)
5 HUMAN MICOBIOME BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Human Micobiome Market Size by Application (2015-2020)
5.2 Global Human Micobiome Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Human Micobiome Market Size (2015-2020)
6.2 Human Micobiome Key Players in North America (2019-2020)
6.3 North America Human Micobiome Market Size by Type (2015-2020)
6.4 North America Human Micobiome Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Human Micobiome Market Size (2015-2020)
7.2 Human Micobiome Key Players in Europe (2019-2020)
7.3 Europe Human Micobiome Market Size by Type (2015-2020)
7.4 Europe Human Micobiome Market Size by Application (2015-2020)
8 CHINA
8.1 China Human Micobiome Market Size (2015-2020)
8.2 Human Micobiome Key Players in China (2019-2020)
8.3 China Human Micobiome Market Size by Type (2015-2020)
8.4 China Human Micobiome Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Human Micobiome Market Size (2015-2020)
9.2 Human Micobiome Key Players in Japan (2019-2020)
9.3 Japan Human Micobiome Market Size by Type (2015-2020)
9.4 Japan Human Micobiome Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Human Micobiome Market Size (2015-2020)
10.2 Human Micobiome Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Human Micobiome Market Size by Type (2015-2020)
10.4 Southeast Asia Human Micobiome Market Size by Application (2015-2020)
11 INDIA
11.1 India Human Micobiome Market Size (2015-2020)
11.2 Human Micobiome Key Players in India (2019-2020)
11.3 India Human Micobiome Market Size by Type (2015-2020)
11.4 India Human Micobiome Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Human Micobiome Market Size (2015-2020)
12.2 Human Micobiome Key Players in Central & South America (2019-2020)
12.3 Central & South America Human Micobiome Market Size by Type (2015-2020)
12.4 Central & South America Human Micobiome Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Vedanta
13.1.1 Vedanta Company Details
13.1.2 Vedanta Business Overview and Its Total Revenue
13.1.3 Vedanta Human Micobiome Introduction
13.1.4 Vedanta Revenue in Human Micobiome Business (2015-2020))
13.1.5 Vedanta Recent Development
13.2 Seres Therapeutics
13.2.1 Seres Therapeutics Company Details
13.2.2 Seres Therapeutics Business Overview and Its Total Revenue
13.2.3 Seres Therapeutics Human Micobiome Introduction
13.2.4 Seres Therapeutics Revenue in Human Micobiome Business (2015-2020)
13.2.5 Seres Therapeutics Recent Development
13.3 Second Genome
13.3.1 Second Genome Company Details
13.3.2 Second Genome Business Overview and Its Total Revenue
13.3.3 Second Genome Human Micobiome Introduction
13.3.4 Second Genome Revenue in Human Micobiome Business (2015-2020)
13.3.5 Second Genome Recent Development
13.4 Rebiotix
13.4.1 Rebiotix Company Details
13.4.2 Rebiotix Business Overview and Its Total Revenue
13.4.3 Rebiotix Human Micobiome Introduction
13.4.4 Rebiotix Revenue in Human Micobiome Business (2015-2020)
13.4.5 Rebiotix Recent Development
13.5 ActoGeniX
13.5.1 ActoGeniX Company Details
13.5.2 ActoGeniX Business Overview and Its Total Revenue
13.5.3 ActoGeniX Human Micobiome Introduction
13.5.4 ActoGeniX Revenue in Human Micobiome Business (2015-2020)
13.5.5 ActoGeniX Recent Development
13.6 Enterome BioScience
13.6.1 Enterome BioScience Company Details
13.6.2 Enterome BioScience Business Overview and Its Total Revenue
13.6.3 Enterome BioScience Human Micobiome Introduction
13.6.4 Enterome BioScience Revenue in Human Micobiome Business (2015-2020)
13.6.5 Enterome BioScience Recent Development
13.7 AvidBiotics
13.7.1 AvidBiotics Company Details
13.7.2 AvidBiotics Business Overview and Its Total Revenue
13.7.3 AvidBiotics Human Micobiome Introduction
13.7.4 AvidBiotics Revenue in Human Micobiome Business (2015-2020)
13.7.5 AvidBiotics Recent Development
13.8 4D Pharma Research Ltd
13.8.1 4D Pharma Research Ltd Company Details
13.8.2 4D Pharma Research Ltd Business Overview and Its Total Revenue
13.8.3 4D Pharma Research Ltd Human Micobiome Introduction
13.8.4 4D Pharma Research Ltd Revenue in Human Micobiome Business (2015-2020)
13.8.5 4D Pharma Research Ltd Recent Development
13.9 Enterologics
13.9.1 Enterologics Company Details
13.9.2 Enterologics Business Overview and Its Total Revenue
13.9.3 Enterologics Human Micobiome Introduction
13.9.4 Enterologics Revenue in Human Micobiome Business (2015-2020)
13.9.5 Enterologics Recent Development
13.10 Metabogen
13.10.1 Metabogen Company Details
13.10.2 Metabogen Business Overview and Its Total Revenue
13.10.3 Metabogen Human Micobiome Introduction
13.10.4 Metabogen Revenue in Human Micobiome Business (2015-2020)
13.10.5 Metabogen Recent Development
13.11 Metabiomics
10.11.1 Metabiomics Company Details
10.11.2 Metabiomics Business Overview and Its Total Revenue
10.11.3 Metabiomics Human Micobiome Introduction
10.11.4 Metabiomics Revenue in Human Micobiome Business (2015-2020)
10.11.5 Metabiomics Recent Development
13.12 Ritter Pharmaceuticals
10.12.1 Ritter Pharmaceuticals Company Details
10.12.2 Ritter Pharmaceuticals Business Overview and Its Total Revenue
10.12.3 Ritter Pharmaceuticals Human Micobiome Introduction
10.12.4 Ritter Pharmaceuticals Revenue in Human Micobiome Business (2015-2020)
10.12.5 Ritter Pharmaceuticals Recent Development
13.13 Osel
10.13.1 Osel Company Details
10.13.2 Osel Business Overview and Its Total Revenue
10.13.3 Osel Human Micobiome Introduction
10.13.4 Osel Revenue in Human Micobiome Business (2015-2020)
10.13.5 Osel Recent Development
13.14 Symberix
10.14.1 Symberix Company Details
10.14.2 Symberix Business Overview and Its Total Revenue
10.14.3 Symberix Human Micobiome Introduction
10.14.4 Symberix Revenue in Human Micobiome Business (2015-2020)
10.14.5 Symberix Recent Development
13.15 Miomics
10.15.1 Miomics Company Details
10.15.2 Miomics Business Overview and Its Total Revenue
10.15.3 Miomics Human Micobiome Introduction
10.15.4 Miomics Revenue in Human Micobiome Business (2015-2020)
10.15.5 Miomics Recent Development
13.16 Symbiotix Biotherapies
10.16.1 Symbiotix Biotherapies Company Details
10.16.2 Symbiotix Biotherapies Business Overview and Its Total Revenue
10.16.3 Symbiotix Biotherapies Human Micobiome Introduction
10.16.4 Symbiotix Biotherapies Revenue in Human Micobiome Business (2015-2020)
10.16.5 Symbiotix Biotherapies Recent Development
13.17 MicroBiome Therapeutics LLC
10.17.1 MicroBiome Therapeutics LLC Company Details
10.17.2 MicroBiome Therapeutics LLC Business Overview and Its Total Revenue
10.17.3 MicroBiome Therapeutics LLC Human Micobiome Introduction
10.17.4 MicroBiome Therapeutics LLC Revenue in Human Micobiome Business (2015-2020)
10.17.5 MicroBiome Therapeutics LLC Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Human Micobiome Key Market Segments
Table 2. Key Players Covered: Ranking by Human Micobiome Revenue
Table 3. Ranking of Global Top Human Micobiome Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Human Micobiome Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Gastrointestinal Tract Human Micobiome
Table 6. Key Players of Urogenital Tract Human Micobiome
Table 7. Key Players of Other
Table 8. COVID-19 Impact Global Market: (Four Human Micobiome Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Human Micobiome Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Human Micobiome Players to Combat Covid-19 Impact
Table 13. Global Human Micobiome Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Human Micobiome Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Human Micobiome Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Human Micobiome Market Share by Regions (2015-2020)
Table 17. Global Human Micobiome Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Human Micobiome Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Human Micobiome Market Growth Strategy
Table 23. Main Points Interviewed from Key Human Micobiome Players
Table 24. Global Human Micobiome Revenue by Players (2015-2020) (Million US$)
Table 25. Global Human Micobiome Market Share by Players (2015-2020)
Table 26. Global Top Human Micobiome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Micobiome as of 2019)
Table 27. Global Human Micobiome by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Human Micobiome Product Solution and Service
Table 30. Date of Enter into Human Micobiome Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Human Micobiome Market Size by Type (2015-2020) (Million US$)
Table 33. Global Human Micobiome Market Size Share by Type (2015-2020)
Table 34. Global Human Micobiome Revenue Market Share by Type (2021-2026)
Table 35. Global Human Micobiome Market Size Share by Application (2015-2020)
Table 36. Global Human Micobiome Market Size by Application (2015-2020) (Million US$)
Table 37. Global Human Micobiome Market Size Share by Application (2021-2026)
Table 38. North America Key Players Human Micobiome Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Human Micobiome Market Share (2019-2020)
Table 40. North America Human Micobiome Market Size by Type (2015-2020) (Million US$)
Table 41. North America Human Micobiome Market Share by Type (2015-2020)
Table 42. North America Human Micobiome Market Size by Application (2015-2020) (Million US$)
Table 43. North America Human Micobiome Market Share by Application (2015-2020)
Table 44. Europe Key Players Human Micobiome Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Human Micobiome Market Share (2019-2020)
Table 46. Europe Human Micobiome Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Human Micobiome Market Share by Type (2015-2020)
Table 48. Europe Human Micobiome Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Human Micobiome Market Share by Application (2015-2020)
Table 50. China Key Players Human Micobiome Revenue (2019-2020) (Million US$)
Table 51. China Key Players Human Micobiome Market Share (2019-2020)
Table 52. China Human Micobiome Market Size by Type (2015-2020) (Million US$)
Table 53. China Human Micobiome Market Share by Type (2015-2020)
Table 54. China Human Micobiome Market Size by Application (2015-2020) (Million US$)
Table 55. China Human Micobiome Market Share by Application (2015-2020)
Table 56. Japan Key Players Human Micobiome Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Human Micobiome Market Share (2019-2020)
Table 58. Japan Human Micobiome Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Human Micobiome Market Share by Type (2015-2020)
Table 60. Japan Human Micobiome Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Human Micobiome Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Human Micobiome Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Human Micobiome Market Share (2019-2020)
Table 64. Southeast Asia Human Micobiome Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Human Micobiome Market Share by Type (2015-2020)
Table 66. Southeast Asia Human Micobiome Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Human Micobiome Market Share by Application (2015-2020)
Table 68. India Key Players Human Micobiome Revenue (2019-2020) (Million US$)
Table 69. India Key Players Human Micobiome Market Share (2019-2020)
Table 70. India Human Micobiome Market Size by Type (2015-2020) (Million US$)
Table 71. India Human Micobiome Market Share by Type (2015-2020)
Table 72. India Human Micobiome Market Size by Application (2015-2020) (Million US$)
Table 73. India Human Micobiome Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Human Micobiome Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Human Micobiome Market Share (2019-2020)
Table 76. Central & South America Human Micobiome Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Human Micobiome Market Share by Type (2015-2020)
Table 78. Central & South America Human Micobiome Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Human Micobiome Market Share by Application (2015-2020)
Table 80. Vedanta Company Details
Table 81. Vedanta Business Overview
Table 82. Vedanta Product
Table 83. Vedanta Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 84. Vedanta Recent Development
Table 85. Seres Therapeutics Company Details
Table 86. Seres Therapeutics Business Overview
Table 87. Seres Therapeutics Product
Table 88. Seres Therapeutics Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 89. Seres Therapeutics Recent Development
Table 90. Second Genome Company Details
Table 91. Second Genome Business Overview
Table 92. Second Genome Product
Table 93. Second Genome Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 94. Second Genome Recent Development
Table 95. Rebiotix Company Details
Table 96. Rebiotix Business Overview
Table 97. Rebiotix Product
Table 98. Rebiotix Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 99. Rebiotix Recent Development
Table 100. ActoGeniX Company Details
Table 101. ActoGeniX Business Overview
Table 102. ActoGeniX Product
Table 103. ActoGeniX Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 104. ActoGeniX Recent Development
Table 105. Enterome BioScience Company Details
Table 106. Enterome BioScience Business Overview
Table 107. Enterome BioScience Product
Table 108. Enterome BioScience Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 109. Enterome BioScience Recent Development
Table 110. AvidBiotics Company Details
Table 111. AvidBiotics Business Overview
Table 112. AvidBiotics Product
Table 113. AvidBiotics Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 114. AvidBiotics Recent Development
Table 115. 4D Pharma Research Ltd Business Overview
Table 116. 4D Pharma Research Ltd Product
Table 117. 4D Pharma Research Ltd Company Details
Table 118. 4D Pharma Research Ltd Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 119. 4D Pharma Research Ltd Recent Development
Table 120. Enterologics Company Details
Table 121. Enterologics Business Overview
Table 122. Enterologics Product
Table 123. Enterologics Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 124. Enterologics Recent Development
Table 125. Metabogen Company Details
Table 126. Metabogen Business Overview
Table 127. Metabogen Product
Table 128. Metabogen Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 129. Metabogen Recent Development
Table 130. Metabiomics Company Details
Table 131. Metabiomics Business Overview
Table 132. Metabiomics Product
Table 133. Metabiomics Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 134. Metabiomics Recent Development
Table 135. Ritter Pharmaceuticals Company Details
Table 136. Ritter Pharmaceuticals Business Overview
Table 137. Ritter Pharmaceuticals Product
Table 138. Ritter Pharmaceuticals Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 139. Ritter Pharmaceuticals Recent Development
Table 140. Osel Company Details
Table 141. Osel Business Overview
Table 142. Osel Product
Table 143. Osel Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 144. Osel Recent Development
Table 145. Symberix Company Details
Table 146. Symberix Business Overview
Table 147. Symberix Product
Table 148. Symberix Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 149. Symberix Recent Development
Table 150. Miomics Company Details
Table 151. Miomics Business Overview
Table 152. Miomics Product
Table 153. Miomics Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 154. Miomics Recent Development
Table 155. Symbiotix Biotherapies Company Details
Table 156. Symbiotix Biotherapies Business Overview
Table 157. Symbiotix Biotherapies Product
Table 158. Symbiotix Biotherapies Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 159. Symbiotix Biotherapies Recent Development
Table 160. MicroBiome Therapeutics LLC Company Details
Table 161. MicroBiome Therapeutics LLC Business Overview
Table 162. MicroBiome Therapeutics LLC Product
Table 163. MicroBiome Therapeutics LLC Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 164. MicroBiome Therapeutics LLC Recent Development
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
Table 1. Human Micobiome Key Market Segments
Table 2. Key Players Covered: Ranking by Human Micobiome Revenue
Table 3. Ranking of Global Top Human Micobiome Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Human Micobiome Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Gastrointestinal Tract Human Micobiome
Table 6. Key Players of Urogenital Tract Human Micobiome
Table 7. Key Players of Other
Table 8. COVID-19 Impact Global Market: (Four Human Micobiome Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Human Micobiome Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Human Micobiome Players to Combat Covid-19 Impact
Table 13. Global Human Micobiome Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Human Micobiome Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Human Micobiome Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Human Micobiome Market Share by Regions (2015-2020)
Table 17. Global Human Micobiome Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Human Micobiome Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Human Micobiome Market Growth Strategy
Table 23. Main Points Interviewed from Key Human Micobiome Players
Table 24. Global Human Micobiome Revenue by Players (2015-2020) (Million US$)
Table 25. Global Human Micobiome Market Share by Players (2015-2020)
Table 26. Global Top Human Micobiome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Micobiome as of 2019)
Table 27. Global Human Micobiome by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Human Micobiome Product Solution and Service
Table 30. Date of Enter into Human Micobiome Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Human Micobiome Market Size by Type (2015-2020) (Million US$)
Table 33. Global Human Micobiome Market Size Share by Type (2015-2020)
Table 34. Global Human Micobiome Revenue Market Share by Type (2021-2026)
Table 35. Global Human Micobiome Market Size Share by Application (2015-2020)
Table 36. Global Human Micobiome Market Size by Application (2015-2020) (Million US$)
Table 37. Global Human Micobiome Market Size Share by Application (2021-2026)
Table 38. North America Key Players Human Micobiome Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Human Micobiome Market Share (2019-2020)
Table 40. North America Human Micobiome Market Size by Type (2015-2020) (Million US$)
Table 41. North America Human Micobiome Market Share by Type (2015-2020)
Table 42. North America Human Micobiome Market Size by Application (2015-2020) (Million US$)
Table 43. North America Human Micobiome Market Share by Application (2015-2020)
Table 44. Europe Key Players Human Micobiome Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Human Micobiome Market Share (2019-2020)
Table 46. Europe Human Micobiome Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Human Micobiome Market Share by Type (2015-2020)
Table 48. Europe Human Micobiome Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Human Micobiome Market Share by Application (2015-2020)
Table 50. China Key Players Human Micobiome Revenue (2019-2020) (Million US$)
Table 51. China Key Players Human Micobiome Market Share (2019-2020)
Table 52. China Human Micobiome Market Size by Type (2015-2020) (Million US$)
Table 53. China Human Micobiome Market Share by Type (2015-2020)
Table 54. China Human Micobiome Market Size by Application (2015-2020) (Million US$)
Table 55. China Human Micobiome Market Share by Application (2015-2020)
Table 56. Japan Key Players Human Micobiome Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Human Micobiome Market Share (2019-2020)
Table 58. Japan Human Micobiome Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Human Micobiome Market Share by Type (2015-2020)
Table 60. Japan Human Micobiome Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Human Micobiome Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Human Micobiome Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Human Micobiome Market Share (2019-2020)
Table 64. Southeast Asia Human Micobiome Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Human Micobiome Market Share by Type (2015-2020)
Table 66. Southeast Asia Human Micobiome Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Human Micobiome Market Share by Application (2015-2020)
Table 68. India Key Players Human Micobiome Revenue (2019-2020) (Million US$)
Table 69. India Key Players Human Micobiome Market Share (2019-2020)
Table 70. India Human Micobiome Market Size by Type (2015-2020) (Million US$)
Table 71. India Human Micobiome Market Share by Type (2015-2020)
Table 72. India Human Micobiome Market Size by Application (2015-2020) (Million US$)
Table 73. India Human Micobiome Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Human Micobiome Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Human Micobiome Market Share (2019-2020)
Table 76. Central & South America Human Micobiome Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Human Micobiome Market Share by Type (2015-2020)
Table 78. Central & South America Human Micobiome Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Human Micobiome Market Share by Application (2015-2020)
Table 80. Vedanta Company Details
Table 81. Vedanta Business Overview
Table 82. Vedanta Product
Table 83. Vedanta Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 84. Vedanta Recent Development
Table 85. Seres Therapeutics Company Details
Table 86. Seres Therapeutics Business Overview
Table 87. Seres Therapeutics Product
Table 88. Seres Therapeutics Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 89. Seres Therapeutics Recent Development
Table 90. Second Genome Company Details
Table 91. Second Genome Business Overview
Table 92. Second Genome Product
Table 93. Second Genome Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 94. Second Genome Recent Development
Table 95. Rebiotix Company Details
Table 96. Rebiotix Business Overview
Table 97. Rebiotix Product
Table 98. Rebiotix Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 99. Rebiotix Recent Development
Table 100. ActoGeniX Company Details
Table 101. ActoGeniX Business Overview
Table 102. ActoGeniX Product
Table 103. ActoGeniX Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 104. ActoGeniX Recent Development
Table 105. Enterome BioScience Company Details
Table 106. Enterome BioScience Business Overview
Table 107. Enterome BioScience Product
Table 108. Enterome BioScience Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 109. Enterome BioScience Recent Development
Table 110. AvidBiotics Company Details
Table 111. AvidBiotics Business Overview
Table 112. AvidBiotics Product
Table 113. AvidBiotics Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 114. AvidBiotics Recent Development
Table 115. 4D Pharma Research Ltd Business Overview
Table 116. 4D Pharma Research Ltd Product
Table 117. 4D Pharma Research Ltd Company Details
Table 118. 4D Pharma Research Ltd Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 119. 4D Pharma Research Ltd Recent Development
Table 120. Enterologics Company Details
Table 121. Enterologics Business Overview
Table 122. Enterologics Product
Table 123. Enterologics Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 124. Enterologics Recent Development
Table 125. Metabogen Company Details
Table 126. Metabogen Business Overview
Table 127. Metabogen Product
Table 128. Metabogen Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 129. Metabogen Recent Development
Table 130. Metabiomics Company Details
Table 131. Metabiomics Business Overview
Table 132. Metabiomics Product
Table 133. Metabiomics Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 134. Metabiomics Recent Development
Table 135. Ritter Pharmaceuticals Company Details
Table 136. Ritter Pharmaceuticals Business Overview
Table 137. Ritter Pharmaceuticals Product
Table 138. Ritter Pharmaceuticals Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 139. Ritter Pharmaceuticals Recent Development
Table 140. Osel Company Details
Table 141. Osel Business Overview
Table 142. Osel Product
Table 143. Osel Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 144. Osel Recent Development
Table 145. Symberix Company Details
Table 146. Symberix Business Overview
Table 147. Symberix Product
Table 148. Symberix Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 149. Symberix Recent Development
Table 150. Miomics Company Details
Table 151. Miomics Business Overview
Table 152. Miomics Product
Table 153. Miomics Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 154. Miomics Recent Development
Table 155. Symbiotix Biotherapies Company Details
Table 156. Symbiotix Biotherapies Business Overview
Table 157. Symbiotix Biotherapies Product
Table 158. Symbiotix Biotherapies Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 159. Symbiotix Biotherapies Recent Development
Table 160. MicroBiome Therapeutics LLC Company Details
Table 161. MicroBiome Therapeutics LLC Business Overview
Table 162. MicroBiome Therapeutics LLC Product
Table 163. MicroBiome Therapeutics LLC Revenue in Human Micobiome Business (2015-2020) (Million US$)
Table 164. MicroBiome Therapeutics LLC Recent Development
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Human Micobiome Market Share by Type: 2020 VS 2026
Figure 2. Gastrointestinal Tract Human Micobiome Features
Figure 3. Urogenital Tract Human Micobiome Features
Figure 4. Other Features
Figure 5. Global Human Micobiome Market Share by Application: 2020 VS 2026
Figure 6. Treatment Case Studies
Figure 7. Diagnosis Case Studies
Figure 8. Human Micobiome Report Years Considered
Figure 9. Global Human Micobiome Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Human Micobiome Market Share by Regions: 2020 VS 2026
Figure 11. Global Human Micobiome Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Human Micobiome Market Share by Players in 2019
Figure 14. Global Top Human Micobiome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Micobiome as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Human Micobiome Revenue in 2019
Figure 16. North America Human Micobiome Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Human Micobiome Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Human Micobiome Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Human Micobiome Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Human Micobiome Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Human Micobiome Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Human Micobiome Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Vedanta Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Vedanta Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 25. Seres Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Seres Therapeutics Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 27. Second Genome Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Second Genome Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 29. Rebiotix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Rebiotix Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 31. ActoGeniX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. ActoGeniX Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 33. Enterome BioScience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Enterome BioScience Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 35. AvidBiotics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. AvidBiotics Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 37. 4D Pharma Research Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. 4D Pharma Research Ltd Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 39. Enterologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Enterologics Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 41. Metabogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Metabogen Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 43. Metabiomics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Metabiomics Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 45. Ritter Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Ritter Pharmaceuticals Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 47. Osel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Osel Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 49. Symberix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Symberix Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 51. Miomics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Miomics Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 53. Symbiotix Biotherapies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Symbiotix Biotherapies Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 55. MicroBiome Therapeutics LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. MicroBiome Therapeutics LLC Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Figure 1. Global Human Micobiome Market Share by Type: 2020 VS 2026
Figure 2. Gastrointestinal Tract Human Micobiome Features
Figure 3. Urogenital Tract Human Micobiome Features
Figure 4. Other Features
Figure 5. Global Human Micobiome Market Share by Application: 2020 VS 2026
Figure 6. Treatment Case Studies
Figure 7. Diagnosis Case Studies
Figure 8. Human Micobiome Report Years Considered
Figure 9. Global Human Micobiome Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Human Micobiome Market Share by Regions: 2020 VS 2026
Figure 11. Global Human Micobiome Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Human Micobiome Market Share by Players in 2019
Figure 14. Global Top Human Micobiome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Micobiome as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Human Micobiome Revenue in 2019
Figure 16. North America Human Micobiome Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Human Micobiome Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Human Micobiome Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Human Micobiome Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Human Micobiome Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Human Micobiome Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Human Micobiome Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Vedanta Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Vedanta Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 25. Seres Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Seres Therapeutics Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 27. Second Genome Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Second Genome Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 29. Rebiotix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Rebiotix Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 31. ActoGeniX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. ActoGeniX Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 33. Enterome BioScience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Enterome BioScience Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 35. AvidBiotics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. AvidBiotics Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 37. 4D Pharma Research Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. 4D Pharma Research Ltd Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 39. Enterologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Enterologics Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 41. Metabogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Metabogen Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 43. Metabiomics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Metabiomics Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 45. Ritter Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Ritter Pharmaceuticals Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 47. Osel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Osel Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 49. Symberix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Symberix Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 51. Miomics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Miomics Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 53. Symbiotix Biotherapies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Symbiotix Biotherapies Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 55. MicroBiome Therapeutics LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. MicroBiome Therapeutics LLC Revenue Growth Rate in Human Micobiome Business (2015-2020)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
